Sunscreen creams containing naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations
Summary Background The aim of this study was to develop sunscreen creams containing polymeric nanoparticles (NPs) of naringenin for photoprotective and antioxidant effects. Methods Polymeric NPs of naringenin were prepared and optimized. The NPs were incorporated into sunscreen creams and evaluated...
Gespeichert in:
Veröffentlicht in: | Photodermatology, photoimmunology & photomedicine photoimmunology & photomedicine, 2018-01, Vol.34 (1), p.69-81 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 81 |
---|---|
container_issue | 1 |
container_start_page | 69 |
container_title | Photodermatology, photoimmunology & photomedicine |
container_volume | 34 |
creator | Joshi, Haritima Hegde, Aswathi R. Shetty, Pallavi K. Gollavilli, Hemanth Managuli, Renuka S. Kalthur, Guruprasad Mutalik, Srinivas |
description | Summary
Background
The aim of this study was to develop sunscreen creams containing polymeric nanoparticles (NPs) of naringenin for photoprotective and antioxidant effects.
Methods
Polymeric NPs of naringenin were prepared and optimized. The NPs were incorporated into sunscreen creams and evaluated for in vitro and in vivo skin retention.
Results
The optimized naringenin NPs showed a size of 131.2 nm, zeta potential −25.4 mV, and entrapment efficiency 32.45%. The absence of drug‐excipient interaction was confirmed by Fourier transform infrared spectroscopy and differential scanning calorimetry. X‐Ray diffraction analysis demonstrated the amorphization of naringenin in nanoparticles. Transmission electron microscopy showed the sphericity of the NPs with the size of |
doi_str_mv | 10.1111/phpp.12335 |
format | Article |
fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_phpp_12335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PHPP12335</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3295-d0bfbb167fb6eb8b5ed2bf89bd37bdf760e8ac395d9840d4bb75ebde77e06ccd3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK1e_AGyZyF1N5tkE29SrBUKFtRz2I-JRpLdsJtU-u_dNn7cnMPMO_DwHh6ELimZ0zA33XvXzWnMWHqEpjQjJCI8p8doSgqSRgnL2QSdef9BCEkSQk_RJM55xgM5Re55MF45AIPDFq3Hyppe1KY2b9gIFw6EHKKxnXB9rRrwt3hpXTs0oq-twRq20NiuBdNjYTQO9Lbunf17thbDVjTDgffn6KQSjYeL7ztDr8v7l8UqWj89PC7u1pFicZFGmshKSprxSmYgc5mCjmWVF1IzLnXFMwK5UKxIdZEnRCdS8hSkBs6BZEppNkPXY69y1nsHVdm5uhVuV1JS7sWVe3HlQVyAr0a4G2QL-hf9MRUAOgKfdQO7f6rKzWqzGUu_AHBjfaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sunscreen creams containing naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations</title><source>Access via Wiley Online Library</source><creator>Joshi, Haritima ; Hegde, Aswathi R. ; Shetty, Pallavi K. ; Gollavilli, Hemanth ; Managuli, Renuka S. ; Kalthur, Guruprasad ; Mutalik, Srinivas</creator><creatorcontrib>Joshi, Haritima ; Hegde, Aswathi R. ; Shetty, Pallavi K. ; Gollavilli, Hemanth ; Managuli, Renuka S. ; Kalthur, Guruprasad ; Mutalik, Srinivas</creatorcontrib><description>Summary
Background
The aim of this study was to develop sunscreen creams containing polymeric nanoparticles (NPs) of naringenin for photoprotective and antioxidant effects.
Methods
Polymeric NPs of naringenin were prepared and optimized. The NPs were incorporated into sunscreen creams and evaluated for in vitro and in vivo skin retention.
Results
The optimized naringenin NPs showed a size of 131.2 nm, zeta potential −25.4 mV, and entrapment efficiency 32.45%. The absence of drug‐excipient interaction was confirmed by Fourier transform infrared spectroscopy and differential scanning calorimetry. X‐Ray diffraction analysis demonstrated the amorphization of naringenin in nanoparticles. Transmission electron microscopy showed the sphericity of the NPs with the size of <200 nm. Cytotoxicity assessment in HaCaT cells indicated non‐toxic nature of naringenin NPs. In vitro skin permeation studies demonstrated that higher amount of naringenin permeated at the end of 12 hours (Q12 hours = 184.03 ± 3.37 μg/cm2) and deposited in the skin (10.38 ± 0.48 μg/cm2) from NPs as compared to plain naringenin. Sunscreen creams (SC1‐SC5) containing plain naringenin or NPs with/without nano‐zinc oxide and nano‐titanium dioxide were prepared and evaluated. Optimized cream (SC5) containing naringenin NPs showed highest SPF value and enhanced skin retention of naringenin in comparison with NPs in suspension form and other cream formulations.
Conclusion
Optimized nanoparticulate sunscreen cream exhibited highest skin retention and negligible skin permeation of naringenin besides showing excellent SPF value.</description><identifier>ISSN: 0905-4383</identifier><identifier>EISSN: 1600-0781</identifier><identifier>DOI: 10.1111/phpp.12335</identifier><identifier>PMID: 28767160</identifier><language>eng</language><publisher>England</publisher><subject>nanoparticles ; naringenin ; skin permeation ; sun protection factor ; sunscreen</subject><ispartof>Photodermatology, photoimmunology & photomedicine, 2018-01, Vol.34 (1), p.69-81</ispartof><rights>2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><rights>2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3295-d0bfbb167fb6eb8b5ed2bf89bd37bdf760e8ac395d9840d4bb75ebde77e06ccd3</citedby><cites>FETCH-LOGICAL-c3295-d0bfbb167fb6eb8b5ed2bf89bd37bdf760e8ac395d9840d4bb75ebde77e06ccd3</cites><orcidid>0000-0002-0642-1928</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fphpp.12335$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fphpp.12335$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28767160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Joshi, Haritima</creatorcontrib><creatorcontrib>Hegde, Aswathi R.</creatorcontrib><creatorcontrib>Shetty, Pallavi K.</creatorcontrib><creatorcontrib>Gollavilli, Hemanth</creatorcontrib><creatorcontrib>Managuli, Renuka S.</creatorcontrib><creatorcontrib>Kalthur, Guruprasad</creatorcontrib><creatorcontrib>Mutalik, Srinivas</creatorcontrib><title>Sunscreen creams containing naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations</title><title>Photodermatology, photoimmunology & photomedicine</title><addtitle>Photodermatol Photoimmunol Photomed</addtitle><description>Summary
Background
The aim of this study was to develop sunscreen creams containing polymeric nanoparticles (NPs) of naringenin for photoprotective and antioxidant effects.
Methods
Polymeric NPs of naringenin were prepared and optimized. The NPs were incorporated into sunscreen creams and evaluated for in vitro and in vivo skin retention.
Results
The optimized naringenin NPs showed a size of 131.2 nm, zeta potential −25.4 mV, and entrapment efficiency 32.45%. The absence of drug‐excipient interaction was confirmed by Fourier transform infrared spectroscopy and differential scanning calorimetry. X‐Ray diffraction analysis demonstrated the amorphization of naringenin in nanoparticles. Transmission electron microscopy showed the sphericity of the NPs with the size of <200 nm. Cytotoxicity assessment in HaCaT cells indicated non‐toxic nature of naringenin NPs. In vitro skin permeation studies demonstrated that higher amount of naringenin permeated at the end of 12 hours (Q12 hours = 184.03 ± 3.37 μg/cm2) and deposited in the skin (10.38 ± 0.48 μg/cm2) from NPs as compared to plain naringenin. Sunscreen creams (SC1‐SC5) containing plain naringenin or NPs with/without nano‐zinc oxide and nano‐titanium dioxide were prepared and evaluated. Optimized cream (SC5) containing naringenin NPs showed highest SPF value and enhanced skin retention of naringenin in comparison with NPs in suspension form and other cream formulations.
Conclusion
Optimized nanoparticulate sunscreen cream exhibited highest skin retention and negligible skin permeation of naringenin besides showing excellent SPF value.</description><subject>nanoparticles</subject><subject>naringenin</subject><subject>skin permeation</subject><subject>sun protection factor</subject><subject>sunscreen</subject><issn>0905-4383</issn><issn>1600-0781</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Lw0AQhhdRbK1e_AGyZyF1N5tkE29SrBUKFtRz2I-JRpLdsJtU-u_dNn7cnMPMO_DwHh6ELimZ0zA33XvXzWnMWHqEpjQjJCI8p8doSgqSRgnL2QSdef9BCEkSQk_RJM55xgM5Re55MF45AIPDFq3Hyppe1KY2b9gIFw6EHKKxnXB9rRrwt3hpXTs0oq-twRq20NiuBdNjYTQO9Lbunf17thbDVjTDgffn6KQSjYeL7ztDr8v7l8UqWj89PC7u1pFicZFGmshKSprxSmYgc5mCjmWVF1IzLnXFMwK5UKxIdZEnRCdS8hSkBs6BZEppNkPXY69y1nsHVdm5uhVuV1JS7sWVe3HlQVyAr0a4G2QL-hf9MRUAOgKfdQO7f6rKzWqzGUu_AHBjfaA</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Joshi, Haritima</creator><creator>Hegde, Aswathi R.</creator><creator>Shetty, Pallavi K.</creator><creator>Gollavilli, Hemanth</creator><creator>Managuli, Renuka S.</creator><creator>Kalthur, Guruprasad</creator><creator>Mutalik, Srinivas</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-0642-1928</orcidid></search><sort><creationdate>201801</creationdate><title>Sunscreen creams containing naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations</title><author>Joshi, Haritima ; Hegde, Aswathi R. ; Shetty, Pallavi K. ; Gollavilli, Hemanth ; Managuli, Renuka S. ; Kalthur, Guruprasad ; Mutalik, Srinivas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3295-d0bfbb167fb6eb8b5ed2bf89bd37bdf760e8ac395d9840d4bb75ebde77e06ccd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>nanoparticles</topic><topic>naringenin</topic><topic>skin permeation</topic><topic>sun protection factor</topic><topic>sunscreen</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joshi, Haritima</creatorcontrib><creatorcontrib>Hegde, Aswathi R.</creatorcontrib><creatorcontrib>Shetty, Pallavi K.</creatorcontrib><creatorcontrib>Gollavilli, Hemanth</creatorcontrib><creatorcontrib>Managuli, Renuka S.</creatorcontrib><creatorcontrib>Kalthur, Guruprasad</creatorcontrib><creatorcontrib>Mutalik, Srinivas</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Photodermatology, photoimmunology & photomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joshi, Haritima</au><au>Hegde, Aswathi R.</au><au>Shetty, Pallavi K.</au><au>Gollavilli, Hemanth</au><au>Managuli, Renuka S.</au><au>Kalthur, Guruprasad</au><au>Mutalik, Srinivas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sunscreen creams containing naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations</atitle><jtitle>Photodermatology, photoimmunology & photomedicine</jtitle><addtitle>Photodermatol Photoimmunol Photomed</addtitle><date>2018-01</date><risdate>2018</risdate><volume>34</volume><issue>1</issue><spage>69</spage><epage>81</epage><pages>69-81</pages><issn>0905-4383</issn><eissn>1600-0781</eissn><abstract>Summary
Background
The aim of this study was to develop sunscreen creams containing polymeric nanoparticles (NPs) of naringenin for photoprotective and antioxidant effects.
Methods
Polymeric NPs of naringenin were prepared and optimized. The NPs were incorporated into sunscreen creams and evaluated for in vitro and in vivo skin retention.
Results
The optimized naringenin NPs showed a size of 131.2 nm, zeta potential −25.4 mV, and entrapment efficiency 32.45%. The absence of drug‐excipient interaction was confirmed by Fourier transform infrared spectroscopy and differential scanning calorimetry. X‐Ray diffraction analysis demonstrated the amorphization of naringenin in nanoparticles. Transmission electron microscopy showed the sphericity of the NPs with the size of <200 nm. Cytotoxicity assessment in HaCaT cells indicated non‐toxic nature of naringenin NPs. In vitro skin permeation studies demonstrated that higher amount of naringenin permeated at the end of 12 hours (Q12 hours = 184.03 ± 3.37 μg/cm2) and deposited in the skin (10.38 ± 0.48 μg/cm2) from NPs as compared to plain naringenin. Sunscreen creams (SC1‐SC5) containing plain naringenin or NPs with/without nano‐zinc oxide and nano‐titanium dioxide were prepared and evaluated. Optimized cream (SC5) containing naringenin NPs showed highest SPF value and enhanced skin retention of naringenin in comparison with NPs in suspension form and other cream formulations.
Conclusion
Optimized nanoparticulate sunscreen cream exhibited highest skin retention and negligible skin permeation of naringenin besides showing excellent SPF value.</abstract><cop>England</cop><pmid>28767160</pmid><doi>10.1111/phpp.12335</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-0642-1928</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0905-4383 |
ispartof | Photodermatology, photoimmunology & photomedicine, 2018-01, Vol.34 (1), p.69-81 |
issn | 0905-4383 1600-0781 |
language | eng |
recordid | cdi_crossref_primary_10_1111_phpp_12335 |
source | Access via Wiley Online Library |
subjects | nanoparticles naringenin skin permeation sun protection factor sunscreen |
title | Sunscreen creams containing naringenin nanoparticles: Formulation development and in vitro and in vivo evaluations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T09%3A20%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sunscreen%20creams%20containing%20naringenin%20nanoparticles:%20Formulation%20development%20and%20in%20vitro%20and%20in%20vivo%20evaluations&rft.jtitle=Photodermatology,%20photoimmunology%20&%20photomedicine&rft.au=Joshi,%20Haritima&rft.date=2018-01&rft.volume=34&rft.issue=1&rft.spage=69&rft.epage=81&rft.pages=69-81&rft.issn=0905-4383&rft.eissn=1600-0781&rft_id=info:doi/10.1111/phpp.12335&rft_dat=%3Cwiley_cross%3EPHPP12335%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/28767160&rfr_iscdi=true |